Search

To form silver nanoparticles by reduction from metal ions in the presence of a reducing agent, D-glucose, a water-soluble derivative of chitosan, succinyl-chitosan, was used as a polymer matrix at room temperature. The synthesis of silver nanoparticles can also be carried out without a reducing agent by thermal activation of the system using an alkali (NaOH) as an accelerator. The presence of silver nanoparticles in the obtained colloidal solutions was judged by the appearance of an absorption band in the electron plasmon resonance spectra (ƛmax = 417 nm). It has been shown that the use of an additional component, polyethylene oxide, in a macromolecular system makes it possible to obtain small silver nanoparticles (1–3 nm). The results of in vitro studies of the antimicrobial activity of the obtained colloidal solutions containing silver nanoparticles confirm that a decrease in the size of silver nanoparticles leads to an expansion of the spectrum of antibacterial activity of strains of gram-positive and gram-negative bacteria (B. subtilis ATCC 6633, S. aureus 209P, E. coli ATCC 25922) and to the manifestation of a pronounced antifungal action in relation to A. niger INA 00760. [ABSTRACT FROM AUTHOR]

Due to the limitation in the current treatment modalities, such as secondary surgery in ACI and fibrocartilage formation in microfracture surgery, various scaffolds or hydrogels have been developed for cartilage regeneration. In the present study, we used sodium periodate to oxidize methylcellulose and formed dialdehyde methylcellulose (DAC) after dialysis and freeze-drying process, DAC was further mixed with succinyl-chitosan (SUC) to form an DAC-SUC in situ forming hydrogel. The hydrogel is a stiffness, elastic-like and porous hydrogel according to the observation of SEM and rheological analysis. DAC-SUC13 hydrogel possess well cell-compatibility as well as biodegradability. Most bone marrow mesenchymal stem cells (BM-pMSCs) were alive in the hydrogel and possess chondrogenesis potential. According to the results of animal study, we found DAC-SUC13 hydrogel can function as a stem cell carrier to promote glycosaminoglycans and type II collagen synthesis in the osteochondral defects of porcine knee. These findings suggested that DAC-SUC13 hydrogel combined with stem cell is a potential treatment for cartilage defects repair in the future. [ABSTRACT FROM AUTHOR]

Due to the limitation in the current treatment modalities, such as secondary surgery in ACI and fibrocartilage formation in microfracture surgery, various scaffolds or hydrogels have been developed for cartilage regeneration. In the present study, we used sodium periodate to oxidize methylcellulose and formed dialdehyde methylcellulose (DAC) after dialysis and freeze-drying process, DAC was further mixed with succinyl-chitosan (SUC) to form an DAC-SUC in situ forming hydrogel. The hydrogel is a stiffness, elastic-like and porous hydrogel according to the observation of SEM and rheological analysis. DAC-SUC13 hydrogel possess well cell-compatibility as well as biodegradability. Most bone marrow mesenchymal stem cells (BM-pMSCs) were alive in the hydrogel and possess chondrogenesis potential. According to the results of animal study, we found DAC-SUC13 hydrogel can function as a stem cell carrier to promote glycosaminoglycans and type II collagen synthesis in the osteochondral defects of porcine knee. These findings suggested that DAC-SUC13 hydrogel combined with stem cell is a potential treatment for cartilage defects repair in the future.

The effects of temperature, reactant ratio, pH, and reaction time were studied on the polymers formed by the reactions of succinic and glutaric anhydrides with chitosan under both homogeneous and heterogeneous conditions. As a result, protocols were developed for the synthesis of succinyl- and glutaryl-chitosan derivatives (SC and GC, respectively) with a specific degree of substitution. The polymers were characterized by NMR spectroscopy, including two-dimensional NMR techniques, that confirms N -substitution of chitosan under reaction conditions used. SC and GC both show pronounced and similar antioxidant activity, which slightly increases with an increase in the degree of substitution. Both SC and GC showed antiplatelet and anticoagulant activity. The platelet aggregation is suppressed more strongly in the experiments with GC than with SC, although the latter exhibits a more pronounced anticoagulant activity. [ABSTRACT FROM AUTHOR]

Nanoparticles of two chitosan derivatives – N -succinyl-chitosan (SC) and N -glutaryl-chitosan (GC) – were developed as passive transport systems for taxanes (paclitaxel and docetaxel) using an ionic gelation technique with sodium tripolyphosphate. These nanoparticles had an apparent hydrodynamic diameter of 300–350 nm, a ζ-potential of 25–31 mV, an encapsulation efficiency of 21–26%, and a drug loading efficiency of 6–13%. DLS and SLS analysis shows that the nanoparticles have a unimodal size distribution and spherical form. Drug release kinetics of the taxane-loaded nanoparticles demonstrates that more than 50% of the loaded taxane could be released upon the degradation of the nanoparticles after targeted delivery. The drug-loaded SC and GC nanoparticles exhibit high cytotoxicity towards AGS cancer cell lines and their antitumor activity is consequently enhanced when compared with free taxanes. [ABSTRACT FROM AUTHOR]

In the present work, quercetin and resveratrol, natural polyphenols with strong antioxidant and anti-inflammatory properties, were co-loaded in polymer-associated liposomes conceived for oral delivery, by exploiting the potential of pH-sensitive succinyl-chitosan. Chitosan was succinylated, characterized by Nuclear Magnetic Resonance spectroscopy and Gel Permeation Chromatography, and used to form a protective shell on the surface of liposomes. The physico-chemical properties of the succinyl-chitosan liposomes were assessed by light scattering, zeta potential, cryogenic transmission electron microscopy, and small angle X-ray scattering. Small, spherical, uni- and bilamellar vesicles were produced. The succinyl-chitosan shell increased not only the physical stability of the vesicular system, as demonstrated by accelerated stability tests, but also the release of the polyphenols to a greater extent at pH 7.0, mimicking the intestinal environment. The proposed approach based on polyphenol vesicular formulations may be of value in the treatment of pre-cancerous/cancerous intestinal conditions associated with inflammation and oxidative stress. [ABSTRACT FROM AUTHOR]

Succinyl-Chitosan (SCS), a water soluble CS derivative, exhibits biocompatibility, low toxicity and long-term retention in the body. SCS offers unique characteristics as polymer for obtaining drug delivery nanosystems, due to its many reactive amino, hydroxyl, and carboxylic acid pendant groups. Chemical modifications of SCS with antibodies and other active species are easily achieved through bonding with these groups, allowing targeting and detection. In this work, SCS was obtained by amidation of primary amine groups of CS with succinic anhydride. The succinylation degree, determined by 1H-NMR, was 28%. Evaluation by zeta potential measurements of SCS showed a pH-dependent charge profile, which can be conveniently exploited to prepare pH-sensitive nanoparticles. Colloidal stable SCS/CS and SCS nanoparticles, useful in drug delivery, were prepared by ionic crosslinking from mixtures of CS and SCS in different weight percentages. Nanoparticles with sizes between 140-250 nm (after purification process) are obtained, which through further surface functionalization are suitable for application in drug delivery. The colloidal stability of the particles in water was studied by particle size measurements during 30 days and aggregation or formation of larger particles was not observed. [ABSTRACT FROM AUTHOR]